These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22347402)

  • 1. CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide.
    Chyu KY; Zhao X; Dimayuga PC; Zhou J; Li X; Yano J; Lio WM; Chan LF; Kirzner J; Trinidad P; Cercek B; Shah PK
    PLoS One; 2012; 7(2):e30780. PubMed ID: 22347402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice.
    Honjo T; Chyu KY; Dimayuga PC; Lio WM; Yano J; Trinidad P; Zhao X; Zhou J; Cercek B; Shah PK
    PLoS One; 2015; 10(6):e0131731. PubMed ID: 26121471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.
    Dimayuga PC; Zhao X; Yano J; Lio WM; Zhou J; Mihailovic PM; Cercek B; Shah PK; Chyu KY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice.
    Chyu KY; Zhao X; Reyes OS; Babbidge SM; Dimayuga PC; Yano J; Cercek B; Fredrikson GN; Nilsson J; Shah PK
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1982-9. PubMed ID: 16288717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
    Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis.
    Chyu KY; Zhao X; Zhou J; Dimayuga PC; Lio NW; Cercek B; Trac NT; Chung EJ; Shah PK
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35536648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoB-100-related peptide vaccine protects against angiotensin II-induced aortic aneurysm formation and rupture.
    Honjo T; Chyu KY; Dimayuga PC; Yano J; Lio WM; Trinidad P; Zhao X; Zhou J; Chen S; Cercek B; Arditi M; Shah PK
    J Am Coll Cardiol; 2015 Feb; 65(6):546-56. PubMed ID: 25677313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses elicited by apoB-100-derived peptides in mice.
    Pierides C; Bermudez-Fajardo A; Fredrikson GN; Nilsson J; Oviedo-Orta E
    Immunol Res; 2013 May; 56(1):96-108. PubMed ID: 23345063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.
    Rattik S; Mantani PT; Yao Mattisson I; Ljungcrantz I; Sundius L; Björkbacka H; Terrinoni M; Lebens M; Holmgren J; Nilsson J; Wigren M; Nordin Fredrikson G
    Vascul Pharmacol; 2018 Dec; 111():54-61. PubMed ID: 30243560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE
    Dunér P; Mattisson IY; Fogelstrand P; Glise L; Ruiz S; Farina C; Borén J; Nilsson J; Bengtsson E
    Sci Rep; 2021 Apr; 11(1):9022. PubMed ID: 33907226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoB-100 and HSP60 peptides exert a synergetic role in inhibiting early atherosclerosis in immunized ApoE-null mice.
    Li J; Zhao X; Zhang S; Wang S; Du P; Qi G
    Protein Pept Lett; 2011 Jul; 18(7):733-40. PubMed ID: 21413922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
    Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
    Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
    Engelbertsen D; Rattik S; Knutsson A; Björkbacka H; Bengtsson E; Nilsson J
    Cardiovasc Res; 2014 Jul; 103(2):304-12. PubMed ID: 24866382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8(+)CD25(+) T cells reduce atherosclerosis in apoE(-/-) mice.
    Zhou J; Dimayuga PC; Zhao X; Yano J; Lio WM; Trinidad P; Honjo T; Cercek B; Shah PK; Chyu KY
    Biochem Biophys Res Commun; 2014 Jan; 443(3):864-70. PubMed ID: 24342615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.
    Kimura T; Tse K; McArdle S; Gerhardt T; Miller J; Mikulski Z; Sidney J; Sette A; Wolf D; Ley K
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H781-H790. PubMed ID: 28087520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
    Fredrikson GN; Söderberg I; Lindholm M; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):879-84. PubMed ID: 12649092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-pulsed splenic dendritic cells prime long-lasting CD8(+) T cell memory in the absence of cross-priming by host APC.
    Livingstone AM; Kuhn M
    Eur J Immunol; 2002 Jan; 32(1):281-90. PubMed ID: 11782019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
    Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
    Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A default pathway of memory CD8 T cell differentiation after dendritic cell immunization is deflected by encounter with inflammatory cytokines during antigen-driven proliferation.
    Pham NL; Badovinac VP; Harty JT
    J Immunol; 2009 Aug; 183(4):2337-48. PubMed ID: 19635915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.
    Ontiveros F; Wilson EB; Livingstone AM
    Immunology; 2011 Apr; 132(4):549-58. PubMed ID: 21255009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.